Becton Dickinson & Co (BDX)
225.45
+3.06
(+1.38%)
USD |
NYSE |
Nov 21, 16:00
225.44
-0.01
(-0.00%)
After-Hours: 20:00
Becton Dickinson Revenue (Quarterly): 5.437B for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.437B |
| June 30, 2024 | 4.99B |
| March 31, 2024 | 5.045B |
| December 31, 2023 | 4.706B |
| September 30, 2023 | 5.087B |
| June 30, 2023 | 4.878B |
| March 31, 2023 | 4.821B |
| December 31, 2022 | 4.586B |
| September 30, 2022 | 4.761B |
| June 30, 2022 | 4.641B |
| March 31, 2022 | 4.75B |
| December 31, 2021 | 4.718B |
| September 30, 2021 | 4.849B |
| June 30, 2021 | 4.607B |
| March 31, 2021 | 4.907B |
| December 31, 2020 | 5.315B |
| September 30, 2020 | 3.741B |
| June 30, 2020 | 3.855B |
| March 31, 2020 | 4.253B |
| December 31, 2019 | 4.225B |
| September 30, 2019 | 4.584B |
| June 30, 2019 | 4.35B |
| March 31, 2019 | 4.195B |
| December 31, 2018 | 4.16B |
| September 30, 2018 | 4.402B |
| Date | Value |
|---|---|
| June 30, 2018 | 4.278B |
| March 31, 2018 | 4.222B |
| December 31, 2017 | 3.08B |
| September 30, 2017 | 3.166B |
| June 30, 2017 | 3.035B |
| March 31, 2017 | 2.969B |
| December 31, 2016 | 2.922B |
| September 30, 2016 | 3.231B |
| June 30, 2016 | 3.198B |
| March 31, 2016 | 3.067B |
| December 31, 2015 | 2.986B |
| September 30, 2015 | 3.06B |
| June 30, 2015 | 3.12B |
| March 31, 2015 | 2.051B |
| December 31, 2014 | 2.051B |
| September 30, 2014 | 2.202B |
| June 30, 2014 | 2.157B |
| March 31, 2014 | 2.072B |
| December 31, 2013 | 2.015B |
| September 30, 2013 | 2.101B |
| June 30, 2013 | 2.053B |
| March 31, 2013 | 2.00B |
| December 31, 2012 | 1.90B |
| September 30, 2012 | 1.967B |
| June 30, 2012 | 1.981B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
3.741B
Minimum
Sep 2020
5.437B
Maximum
Sep 2024
4.709B
Average
4.756B
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Abbott Laboratories | 10.64B |
| Baxter International Inc | 2.699B |
| Merit Medical Systems Inc | 339.84M |
| ResMed Inc | 1.225B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 421.00M |
| Total Expenses (Quarterly) | 4.617B |
| EPS Diluted (Quarterly) | 1.45 |
| Enterprise Value | 83.11B |
| Gross Profit Margin (Quarterly) | 46.26% |
| Profit Margin (Quarterly) | 7.74% |
| Earnings Yield | 2.63% |
| Operating Earnings Yield | 4.40% |
| Normalized Earnings Yield | 3.224 |